Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon B Mills

Showing results (11-20 of 826) with videos related to

Pageof 83
Sort By:
Nature Reviews. Clinical Oncology|August 2, 2012
Overcoming implementation challenges of personalized cancer therapyFunda Meric-Bernstam, Gordon B Mills
Drug Metabolism and Pharmacokinetics|January 30, 2016
New era of integrated cancer biomarker discovery using reverse-phase protein arraysSatoshi S Nishizuka, Gordon B Mills
Nature Reviews. Cancer|August 2, 2003
The emerging role of lysophosphatidic acid in cancerGordon B Mills, Wouter H Moolenaar
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2010
Are oncogenes sufficient to cause human cancer?Scott E Woodman, Gordon B Mills
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Personalizing therapy for ovarian cancer: BRCAness and beyondRobert C Bast, Gordon B Mills
Cancer Discovery|May 16, 2012
Dissecting "PI3Kness": the complexity of personalized therapy for ovarian cancerRobert C Bast, Gordon B Mills
Pharmacogenomics|January 26, 2016
Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatmentLydia Wt Cheung, Gordon B Mills
Molecular & Cellular Oncology|June 17, 2016
p85α neomorphic mutants: splitting away from the canonical pathLydia Wt Cheung, Gordon B Mills
Cancer Discovery|November 4, 2015
Large-Scale Drug Screens Support Precision MedicineJoe W Gray, Gordon B Mills
Oncoscience|October 2, 2015
Targeting ncRNAs in the 3q26.2 ampliconPradeep Chaluvally-Raghavan, Gordon B Mills
Pageof 83

Showing results (11-20 of 826) with videos related to

Sort By:
Pageof 83
Nature Reviews. Clinical Oncology|August 2, 2012
Overcoming implementation challenges of personalized cancer therapyFunda Meric-Bernstam, Gordon B Mills
Drug Metabolism and Pharmacokinetics|January 30, 2016
New era of integrated cancer biomarker discovery using reverse-phase protein arraysSatoshi S Nishizuka, Gordon B Mills
Nature Reviews. Cancer|August 2, 2003
The emerging role of lysophosphatidic acid in cancerGordon B Mills, Wouter H Moolenaar
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2010
Are oncogenes sufficient to cause human cancer?Scott E Woodman, Gordon B Mills
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Personalizing therapy for ovarian cancer: BRCAness and beyondRobert C Bast, Gordon B Mills
Cancer Discovery|May 16, 2012
Dissecting "PI3Kness": the complexity of personalized therapy for ovarian cancerRobert C Bast, Gordon B Mills
Pharmacogenomics|January 26, 2016
Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatmentLydia Wt Cheung, Gordon B Mills
Molecular & Cellular Oncology|June 17, 2016
p85α neomorphic mutants: splitting away from the canonical pathLydia Wt Cheung, Gordon B Mills
Cancer Discovery|November 4, 2015
Large-Scale Drug Screens Support Precision MedicineJoe W Gray, Gordon B Mills
Oncoscience|October 2, 2015
Targeting ncRNAs in the 3q26.2 ampliconPradeep Chaluvally-Raghavan, Gordon B Mills
Pageof 83